Intrahepatic cholestasis of pregnancy: Molecular pathogenesis, diagnosis and management

Journal of Hepatology

Volumn 33, Issue 6, 2000, Pages 1012-1021

  Lammert, Frank ^a   Marschall, Hanns Ulrich ^b   Glantz, Anna ^c   Matern, Siegfried ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANION EXCHANGE RESIN; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CHOLIC ACID; COLESTIPOL; COLESTYRAMINE; ESTROGEN DERIVATIVE; PHENOBARBITAL; PROGESTERONE DERIVATIVE; S ADENOSYLMETHIONINE; URSODEOXYCHOLIC ACID;

BILE SECRETION; CARDIOTOCOGRAPHY; DRUG INDUCED DISEASE; FETUS MORTALITY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION TEST; MATERNAL MORBIDITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK FACTOR; THIRD TRIMESTER PREGNANCY;

EID: 0033651377     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80139-7     Document Type: Review

References (135)

1. Berichte und Arbeiten aus der Geburtshilflich-Gynakologischen Klinik zu Giessen 1881-1882
2. Female sex steroids and cholestasis
3. Intrahepatic cholestasis of pregnancy: A French prospective study
4. Fetal outcome in obstetric cholestasis
5. Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome
6. A prospective study of 18 patients with cholestasis of pregnancy
7. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital
8. Intrahepatic cholestasis of pregnancy: Perinatal outcome associated with expectant management
9. Cholestasis of pregnancy. Clinical and laboratory studies
10. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy
11. The effect of estrogen on bile formation in the rat
12. +-ATPase and bile flow by estrogen: Effects on liver surface membrane lipid structure and function
13. The role of sex hormones and hepatic plasma membranes in the pathogenesis of cholestasis
14. +-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis
15. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters
16. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
17. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
18. Steroid D-ring glucuronides: Characterization of a new class of cholestatic agents in the rat
19. Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum
20. Estrogen cholestasis. Membranes, metabolites, or receptors?
21. The adverse influence of pregnancy upon sulphation: A clue to the pathogenesis of intrahepatic cholestasis of pregnancy?
22. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy
23. Obstetric hepatosis: Treatment with cholestyramine and interim response to steroids
24. Intrahepatic cholestasis of pregnancy
25. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels
26. Effect of maternal intrahepatic cholestasis on fetal steroid metabolism
27. Abnormal steroid sulfate in plasma of women with intrahepatic cholestasis of pregnancy
28. Gas chromatographic determination of steroid sulphates in plasma during pregnancy
29. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy
30. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy
31. Exertion of progesterone metabolites in urine and bile of pregnant women with intrahepatic cholestasis
32. Excretion of neutral steroids in urine and faeces of women with intrahepatic cholestasis of pregnancy
33. The identification of novel steroid N-acetylglucosaminides in the urine of pregnant women
34. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans
35. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine
36. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease
37. Prevalence of intrahepatic cholestasis of pregnancy in Chile
38. Familial recurrent intrahepatic cholestasis of pregnancy: A genetic study providing evidence for transmission of a sex-limited, dominant trait
39. Idiopathic cholestasis of pregnancy in a large kindred
40. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters
41. Itching in pregnancy. A 15-year follow-up study
42. Inheritance of intrahepatic cholestasis of pregnancy in one kindred
43. Molecular pathogenesis of cholestasis
44. Cracking the genetic code for benign recurrent and progressive familial intrahepatic cholestasis
45. The molecular genetics of familial intrahepatic cholestasis
46. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
47. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
48. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
49. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?
50. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred
51. Clinical and biochemical findings in progressive familial intrahepatic cholestasis
52. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
53. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: Evidence for a defect in protein trafficking
54. Role of multidrug resistance P-glycoproteins in cholesterol esterification
55. Fetal prognosis in obstetric hepatosis
56. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals in Chile
57. Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy
58. Fetal complications of obstetric cholestasis
59. Doppler umbilical artery velocimetry in pregnancies complicated by intrahepatic cholestasis
60. Effects of cholic acid infusion in fetal lambs
61. Meconium-induced vasocontraction: A potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome
62. Meconium-induced umbilical cord vascular necrosis and ulceration: A potential link between the placenta and poor pregnancy outcome
63. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration
64. Amniotic fluid bile acids in normal and pathologic pregnancy
65. Fetal bile acid levels in pregnancies complicated by maternal intrahepatic cholestasis
66. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment
67. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins
68. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta
69. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem
70. Prolonged postpartum course of intrahepatic cholestasis of pregnancy
71. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease
72. Studies in cholestasis of pregnancy. V. Gallbladder disease, liver function tests, serum lipids and fatty acid composition of serum lecithin in the non-pregnant state
73. Pregnancy and gallstones
74. Jaundice in pregnancy. A follow-up study of the series of women originally reported by L. Thorling. II. Present health of the women
75. Gallbladder function and maternal bile acids in intrahepatic cholestasis of pregnancy
76. Gall bladder volume and serum bile acids in cholestasis of pregnancy
77. Pathogenesis of cholesterol gallstones: A parsimonious hypothesis
78. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: A murine 'gallstone map'
79. Evaluation of abnormal liver-enzyme results in asymptomatic patients
80. Plasma proteins after use of estrogen and-or progestogen in women with and without recurrent cholestasis during previous pregnancies
81. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis
82. Determination of serum bile acids by glass capillary gas-liquid chromatography
83. Serum bile acids in cholestasis of pregnancy
84. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy
85. Serum bile acids in normal pregnancy
86. Serum bile acid levels in pregnancy with pruritus (bile acids and steroids 158)
87. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy
88. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy
89. Biliary bile acids in uncomplicated pregnancy and in cholestasis of pregnancy
90. Liver disease in pregnancy
91. Plasma protein pattern in recurrent cholestasis of pregnancy
92. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse
93. Recurrent jaundice in pregnancy. I. A clinical and ultrastructural study
94. Der Schwangerschaftsikterus
95. Intrahepatic cholestasis of pregnancy: An estrogen-related disease
96. The pruritus of cholestasis
97. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man
98. Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy
99. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration
100. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study
101. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: A randomized, double-blind, placebo-controlled study with negative results
102. Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy
103. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine
104. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone
105. Ursodeoxycholic acid in the Ursidae: Biliary bile acids of bears, pandas, and related carnivores
106. Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications
107. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
108. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
109. Urso - Panacea or placebo?
110. Ursodeoxycholic acid for primary biliary cirrhosis: Lessons from the past - Issues for the future
111. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: Preliminary results of a controlled trial
112. Ursodeoxycholic acid therapy in pregnant women with cholestasis
113. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: A randomized, double-blind study controlled with placebo
114. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy
115. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy
116. Elevated levels of bile: Acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy
117. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid
118. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy
119. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy
120. Management of intrahepatic cholestasis in pregnancy
121. Obstetric cholestasis and pruritus of pregnancy
122. Jaundice in pregnancy
123. Prevalence of intrahepatic cholestasis of pregnancy in La Paz, Bolivia
124. Obstetric cholestasis. A 14 year review
125. Intrahepatic cholestasis of pregnancy and its complications. Analysis of 100 cases in Chongqing area
126. Intrahepatic cholestasis of pregnancy. Clinical analysis and follow-up study of 22 cases
127. Ictere cholestatique recidivant de la grossesse
128. Signification du prurit au cours de la grossesse
129. Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women
130. Jaundice in pregnancy. I. Biochemical assays
131. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in a high incidence area: Portugal
132. Hepatitis in pregnancy
133. Cholestatic jaundice of pregnancy: New perspectives
134. The liver in pregnancy